FindTrial
Sign In

Comparing Light Therapy and Medications for Jaw Muscle Pain Relief

Evaluating the relative efficacy of photobiomodulation and pharmacotherapeutic agents in the symptomatic management of myogenous temporomandibular disorders - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094267
Enrollment
30
Registered
2025-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M266- Temporomandibular joint disorders

Interventions

Intervention1: Photobiomodulation: 1064nm Nd:YAG, 0.6W/cm2 for 60 seconds per cycle for two cycles for 7 days Control Intervention1: Ibuprofen-400mg, Paracetomol-325mg, Chlorozoxazon-250mg: twice dail

Sponsors

Dr Javvadi Durga Keerthi Mounavica
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as myogenous Temporomandibular joint disorders based on research diagnostic criteria

Exclusion criteria

Exclusion criteria: 1.Previously treated/ ongoing treatment/ any recurrence. 2.History of Macro trauma 3.Patients with Renal impairment and Hepatotoxicity

Design outcomes

Primary

MeasureTime frame
Evaluation of pain reductionTimepoint: Evaluation of pain reduction- baseline, day 0, 2, 4, 6 (postperatively)—

Secondary

MeasureTime frame
Increase in Mouth OpeningTimepoint: baseline, day-2, day-4, day-6, 1-month, 2-month & 3-month—

Countries

India

Contacts

Public ContactDr KJyothirmai

Vishnu Dental College

jyothirmaik@vdc.edu.in9866432477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026